Status:
COMPLETED
Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease Study
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
AMD
Age- Related Macular Degeneration
Eligibility:
All Genders
50-85 years
Brief Summary
Background: \- The Age-Related Eye Disease 2 Study (AREDS2) looked at two eye diseases. These were age-related macular degeneration (AMD) and cataracts. Participants in that study took supplement pil...
Detailed Description
The Age Related Eye Disease Study 2 (AREDS2) was a multicenter Phase III randomized clinical trial designed to assess the effects of oral supplementation of high doses of macular xanthophylls (lutein ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- Participants will be eligible if they:
- Were enrolled in the AREDS2 protocol and successfully completed the final AREDS2 follow-up visit.
- Can understand and provide informed consent.
- EXCLUSION CRITERIA
- Participants will not be eligible if they:
- 1\. Are not able to return to NIH for examination for follow up visits.
Exclusion
Key Trial Info
Start Date :
July 16 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 20 2014
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT01915238
Start Date
July 16 2013
End Date
June 20 2014
Last Update
August 30 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
2
Duke Univiversity Eye Center
Durham, North Carolina, United States